[Asia Economy Reporter Minwoo Lee] Aptabio announced on the 9th that it has jointly obtained a patent for an 'ophthalmic disease treatment composition' with Samjin Pharmaceutical.
The patent relates to a pharmaceutical composition for treating ophthalmic diseases containing pyrazole-based compounds and biodegradable polymers. The composition allows the drug to reach the posterior segment of the eye while simultaneously extending the duration of the drug's action within the eye. Aptabio plans to utilize this patent in the development of treatments for ophthalmic diseases.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
